Long‐term efficacy and safety of CT‐P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study

2019 ◽  
Vol 34 (9) ◽  
pp. 1523-1532 ◽  
Author(s):  
Nam Hee Kim ◽  
Ji Hyun Lee ◽  
Sung Noh Hong ◽  
Hyuk Yoon ◽  
Hyoun Woo Kang ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Multicenter Study ◽  
Bowel Disease ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Inflammatory Bowel ◽  
Retrospective Multicenter Study

scholarly journals Thioguanine in inflammatory bowel disease: Long‐term efficacy and safety

2017 ◽  
Vol 5 (4) ◽  
pp. 563-570 ◽  
Author(s):  
Mark G Ward ◽  
Kamal V Patel ◽  
Viraj C Kariyawasam ◽  
Rishi Goel ◽  
Ben Warner ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Inflammatory Bowel

Thiopurines Treatment in Children with Inflammatory Bowel Disease: A Survival Analysis of the Long Term Efficacy

2017 ◽  
Vol 152 (5) ◽  
pp. S391 ◽  
Author(s):  
Eve Sedillot-Daniel ◽  
Audrey Désilets ◽  
Alexandra Verreault ◽  
France Gervais ◽  
Colette Deslandres ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Survival Analysis ◽  
Bowel Disease ◽  
Term Efficacy ◽  
Inflammatory Bowel

scholarly journals 1147 Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

2019 ◽  
Vol 114 (1) ◽  
pp. S643-S644
Author(s):  
Harry E. Sarles ◽  
Annette E. Whitney ◽  
Samantha A. Kuten ◽  
Lucinda J. Van Anglen
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Pediatric Inflammatory Bowel Disease ◽  
Term Efficacy ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document